Novel methods of treating hearing loss
US-2024390323-A1 · Nov 28, 2024 · US
Compositions and methods for treating cancer with aberrant lipogenic signaling
US9750758B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9750758-B2 |
| Application number | US-201314410352-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 10, 2013 |
| Priority date | Jun 25, 2012 |
| Publication date | Sep 5, 2017 |
| Grant date | Sep 5, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The technology described herein relates to pinacolyl boronate substituted stilbenes for the treatment of cancers, e.g. cancers expressing abnormally high levels of SREBP1. Exemplary pinacolyl boronate stilbenes include the following:
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating endometrial cancer in a subject, the method comprising administering to the subject an inhibitor of sterol regulatory binding protein 1 (SREBP1) selected from the group consisting of:
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9750758B2 cover?
- The technology described herein relates to pinacolyl boronate substituted stilbenes for the treatment of cancers, e.g. cancers expressing abnormally high levels of SREBP1. Exemplary pinacolyl boronate stilbenes include the following:
- Who is the assignee on this patent?
- Univ Jefferson
- What technology area does this patent fall under?
- Primary CPC classification A61K31/69. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).